Key result
Nonoperated prosthetic valve endocarditis was associated with a high 1-year mortality rate of 24%, whereas relapses and reinfections were rare at 5% each.
Why the study?
Long-term outcome in nonoperated prosthetic valve endocarditis is largely unknown.
In nonoperated patients with prosthetic valve endocarditis alive at discharge, 1-year mortality is high (24%), but relapses and reinfections are rare (5% each).
Answers are grounded in this paper and cite their sources.
Supports close post-discharge surveillance in nonoperated PVE; leaves open enterococcal relapse prevention strategies.
In nonoperated prosthetic valve endocarditis (PVE), long-term outcome is largely unknown. We report the follow-up of 129 nonoperated patients with PVE alive at discharge. At 1 year, the mortality rate was 24%; relapses and reinfection were rare (5% each). Enterococcal PVE was associated with a higher risk of relapse.
No takes yet. Share an insight, caveat, or question.
Lecomte et al. (2019) studied this question. Nonoperated prosthetic valve endocarditis was associated with a high 1-year mortality rate of 24%, whereas relapses and reinfections were rare at 5% each.
Synapse has enriched 10 related papers. Consider them for comparative context: